• CF PharmTech, Inc. Closes a US $50M Series F Financing to Accelerate the 2020-07-03
    CF PharmTech, Inc. ("CF PharmTech") announced today that it has raised US $50M in Series F financing following its US $90M Series E financing in January of 2020, in
  • Rhinitis: Global Overview 2016-05-06
    Global Resources in Allergy (GLORIA) - a worldwide dissemination of best practice guidelines for the treatment of allergic disease and the next WAO initiative to be posted on GAIN -
  • How Does COPD Affect your Body 2016-05-06
    COPD is a progressive lung disease, which means it gets worse over time.
  • How Serious Is COPD 2016-05-06
    COPD is the third leading cause of death in the United States. More than 11 million people have been diagnosed with COPD, but an estimated 24 million may have the disease without eve
  • Asthma Prevention 2016-05-06
    For people with asthma, having an asthma management plan is the best way to prevent symptoms. An asthma management plan is something developed by you and your doctor to help you cont
  • Asthma Diagnosis 2016-05-06
    To diagnose asthma, your doctor will discuss your medical history with you and perform a physical exam. You may need a lung function test and maybe other tests, such as a chest or si
  • Mark Your Calendar and Plan to Attend RDD Asia 2016 2016-05-06
    Following the success of our first RDD Asia conference in 2014, RDD Asia 2016 will return to Goa, India and be held at the Grand Hyatt Hotel, November 8-11, 2016.
  • RDD 2016 Phoenix, Arizona 2016-05-06
    Respiratory Drug Delivery (RDD?) 2016 was held at the Westin Kierland Resort & Spa, Phoenix, Arizona, April 17-21, 2016.
  • GSK’s Advair Diskus achieves primary endpoint in LABA safety study of ch 2016-01-19
    GSK’s Advair Diskus achieves primary endpoint in LABA safety study of children aged 4-11 years with asthma
    GlaxoSmithKline plc (LSE/NYSE:GSK) today announced results from the paediatric ‘LABA’ (long acting beta2-agonist) safety study. VESTRI (SAS115358) compared Advair? Diskus? (FSC), a